A natural carrier effect and the generation of specific antibodies to biologically active peptides

Analytical Biochemistry
Lilian R TsurutaOsvaldo A Sant'Anna

Abstract

Production of specific antibodies to haptens, especially antipeptides, without interference by carrier protein, is desirable. The bradykinin-potentiating peptides (BPPs) are a family of pyroglutamyl proline-rich oligopeptides with strong antihypertensive properties. In this work, the production of antibodies to BPPs by use of an efficient immunization protocol in mice genetically modified for the high antibody responsiveness (H(III) line) is described. Although it was possible to induce antibody production by single-dose administration of free BPPs, higher antibody titers were obtained in mice preimmunized with carrier protein before administration of peptides conjugated to this carrier. Interestingly, both mouse groups had a higher titer of IgG(1) than IgG(2a) isotypes, regardless of prior immunization with the carrier protein. However, a lower titer of IgG(2a) was observed in unprimed mice. A single band of about 27kDa corresponding to the BPP precursor protein was recognized by these antibodies in the cytosol of the Bothrops jararaca venom gland. This work proposes an efficient immunization protocol based on classic studies described for the hapten-carrier effect for generating specific antibodies against biologically active...Continue Reading

References

Jan 1, 1975·The Journal of Allergy and Clinical Immunology·J F Miller
Dec 1, 1985·Molecular Immunology·C O JacobM Sela
Jun 1, 1986·Molecular Immunology·S MullerM H Van Regenmortel
Jan 1, 1973·Advances in Experimental Medicine and Biology·H N Claman
Jun 1, 1982·The Journal of Experimental Medicine·L A Herzenberg, T Tokuhisa
Jun 1, 1982·The Journal of Experimental Medicine·L A HerzenbergL A Herzenberg
Jan 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·G M MüllerR Arnon
Feb 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·M Z Atassi, R G Webster
Aug 1, 1981·Chemical & Pharmaceutical Bulletin·K ImakiT Okegawa
Jun 26, 1980·Nature·L A HerzenbergL A Herzenberg
Apr 26, 1995·Journal of Immunological Methods·G Houen, O M Jensen
Jan 15, 1994·European Journal of Biochemistry·L LederH R Bosshard
Feb 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·N MurayamaA C de Camargo
Oct 3, 1999·Vaccine·D C JacksonW Zeng
Aug 10, 2000·Journal of Immunoassay·M H van Regenmortel
Jul 27, 2001·Combinatorial Chemistry & High Throughput Screening·M H Van Regenmortel, L Choulier
Oct 4, 2003·Nature Reviews. Drug Discovery·Richard J Lewis, Maria L Garcia
Jun 1, 2005·Toxicon : Official Journal of the International Society on Toxinology·Mirian A F Hayashi, Antonio C M Camargo

❮ Previous
Next ❯

Citations

Oct 1, 2011·PloS One·Eliana B MarengoOsvaldo Augusto Sant'Anna

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.